News Daily News Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding L.A. McKeown May 16, 2025
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News TCT 2024 PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE Todd Neale October 29, 2024
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News Hints of Benefit With Catheter-Directed Thrombolysis in Intermediate/High-Risk PE Todd Neale October 19, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b Shelley Wood June 22, 2021
News Daily News EXTRACT-PE: Positive Results With Aspiration Thrombectomy for Submassive PE Todd Neale January 15, 2021
News Opinion Off Script Off Script: Through ‘Paclitaxelgate,’ Some Upsides to Uncertainty Sahil Parikh, MD July 29, 2019
News Daily News NOACs Significantly Curb Risk of VTE in Cancer Patients L.A. McKeown December 06, 2018
News Daily News Questions Over Risk-Benefit Balance for IVC Filters Still Vex Clinicians Caitlin E. Cox November 17, 2016